Optimization of the properties of brain specific chemical delivery systems by structural modifications

Current Medicinal Chemistry

Volumn 4, Issue 5, 1997, Pages 279-294

  Pop, Emil ^a  

^a Pharmos Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; AMPICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CLOXACILLIN; ESTRADIOL; METICILLIN; NUCLEOSIDE ANALOG; OXACILLIN; PENICILLIN G; PENICILLIN G DERIVATIVE; PHENYTOIN; PRODRUG; PYRIDINIUM DERIVATIVE; ZIDOVUDINE;

BLOOD BRAIN BARRIER; CHEMICAL MODIFICATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; DRUG TRANSPORT; HUMAN; HYDRATION; LIPOPHILICITY; MOLECULAR STABILITY; NONHUMAN; REVIEW;

EID: 0030763403     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Neuwelt, E. Implications of the Blood-Brain Barrier in Physiology and Medicine, Plenum Press, New York, 1989.
2. Rapaport, S. The Blood-Brain Barrier in Physiology and Medicine. Raven Press, New York, 1976.
3. Suckling, A.; Rumbsby, M.; Bradbury, M. The Blood-Brain Barrier in Health and Disease. VCH Publishers, Chichester, England, 1986.
4. Reese, B.; Kamovsky, M. J. Cell Biol. 1967, 34,207.
5. Bodor, N. Drugs. Fut., 1981, 3,165.
6. Bodor, N. In Theory and Application of Bioreversible Carriers to Drug Design, Roch, E.B., Ed.; Pergamon, New York, 1985, pp 95-120.
7. Bodor, N. Ann. N.Y. Acad. Sci., 1987,507,289.
8. Bodor, N.; Farag, H. J. Pharm. Sci., 1984, 73, 385.
9. Bodor, N.; McCormack, F.; Brewster, M. Int. J. Pharm., 1987, 35,47.
10. Brewster, M.; Estes, K.; Bodor, N. J. Med. Chem., 1980, 31,244.
11. Brewster, M.; Estes, K.; Bodor, N Pharm. Res., 1986, 3,278.
12. Anderson, W.; Simpkins, J.; Brewster, M.; Bodor, N. Neuroendocrinology, 1989, 50, 9.
13. Pop, E.; Wu, W. M.; Shek, E.; Bodor, N. J Med. Chem, 1989, 32, 1774.
14. Wu, W. M.; Pop, E.; Shek, E.; Bodor, N. J. Med. Chem, 1989, 32, 1782.
15. Wu, W. M.; Pop, E.; Shek, E.; Clemmons, R.; Bodor, N. Drug Design Deliv., 1991, 7, 33.
16. Pop, E.; Wu, W. M.; Bodor, N. J. Med. Chem., 1989, 32, 1789.
17. Pop, E.; Brewster, M. E.; Bodor, N. Drugs Fut., 1990, 15, 673.
18. Pop, E. Adv. Drug Deliv. Review, 1994, 14,211.
19. Raghavan, K.; Shek, E.; Bodor, N. Anti-Cancer Drug Design, 1987, 2, 25.
20. Bodor, N.; Venkatraghavan, V.; Winwood, D.; Estes, K.; Brewster, M. Int. J. Pharm., 1989, 53, 195.
21. El-Koussi, A.; Bodor, N. Drug Design Deliv. 1987, 1, 275.
22. Aggarawal, S. K.; Gogu, S. R.; Rangan, S. R. S.; Agrawal, K. C. J. Med. Chem., 1990, 33, 1505.
23. Chu, C. K.; Bhadti, V. S.; Doshi, K. J.; Etse, J. T.; Gallo, J. M., Boudinot, F. D.; Schinazi, R. F. J. Med. Chem., 1990, 33,2188.
24. Torrence, P. F.; Kijo, J.; Lesiak, K.; Balzarini, J.; De Clerq, E. FEBBS Lett., 1988, 234, 135.
25. Little, R.; Bailey, D.; Brewster, M.; Estes, K.; Clemmons, R.; Saab, A.; Bodor, N. J. Biopharm. Sci, 1990, 1,1.
26. Pop, E., Anderson, W.; Vlasak, J.; Brewster, M.E.; Bodor, N. Int. J. Pharmaceutics, 1992, 84, 39.
27. Pop, E.; Shek, E.; Murakami, T.; Bodor, N. J. Pharm. Sci., 1989, 78, 609.
28. Murakami, T.; Shek, E.; Pop, E ; Bodor, N. J. Pharm. Sci., 1989, 78, 732.
29. Shek, E.; Murakami, T.; Nath, C., Pop, E.; Bodor, N.; J. Pharm. Sci., 1989, 78, 837.
30. Pop, E.; Brewster, M.E.; Bodor, N. Drugs Fut, 1991 ,16, 221.
31. Pop, E.; Bodor, N. Epilepsy Res., 1992, 13, 1.
32. Pop, E.; Anderson, W.; Prokai-Tatrai, K.; Brewster, M.E., Fregly, M.; Bodor, N., J. Med. Chem., 1990, 33, 2216.
33. Pop, E.; Wu, W. M.; Shek, E.; Bodor, N. Drug Design Deliv., 1989, 5, 93.
34. Prokai-Tatrai, K.; Pop, E.; Anderson, W.; Lin, J.L.; Brewster, M.E.; Bodor, N. J. Pharm. Sci., 1990, 80, 255.
35. Pop, E., Brewster, M. E., Bodor, N. Drugs Fut., 1991, 16, 919.
36. Norby, R. Scand. J. Infect. Dis. Suppl., 1978, 14, 296.
37. Wellman, W E.; Dodge, H. W., Heilman, F. R.; Peterson, M. C. J. Lab. Clin. Med, 1954, 43, 275.
38. Levin, V. J. Med. Chem., 1980, 23, 682.
39. Fenstermacher, J. Trend. Neurol. Sci., 1985, 8, 449.
40. Bodor, N.; Gabanyi, Z.; Wong, C-K. J. Am. Chem. Soc., 1989, 111, 3783.
41. Hansch, C.; Fujita, T. J. Am. Chem. Soc., 1964, 84, 1616.
42. Fujita, T.; Iwasa, J.; Hansch, C. J. Am. Chem. Soc., 1964, 86, 5175.
43. Bate-Smith, E. C.; Westall, R. G. Biochim. Biophys. Acta., 1950, 4,427.
44. Boyce, C. B. G.; Milborrow, B. V. Nature, 1965, 208,537.
45. Biagi, G., L.; Barbara, A. M.; Gamba, M. F.; Guerra, M. C., J. Chromatogr., 1969, 41, 371.
46. Yamana, T.; Tsuji, A.; Miyamoto, E.; Kubo, E. J. Pharm. Sci., 1977, 66, 747.
47. Brewster, M. E.; Huang, M-J.; Bodor, N.; Pop, E. Int. J. Quantum. Chem., Quantum Biol. Symposium, 1996, 23, 1829.
48. Brewster, M. E ; Pop, E ; Braunstein, A. J.; Pop, A. C.; Druzgala, P.; Dinculescu, A/; Anderson, W.; Elkoussi, A.; Bodor, N. Pharm. Res., 1993, 10, 1356.
49. Pop, E.; Liu, Z. Z.; Vlasak, J.; Anderson, W.; Brewster, M. E.; Bodor, N. Drug Delivery, 1993, 1, 143.
50. Brewster, M. E., Bartruff, M. S.; Anderson W. R.; Druzgala, P. J.; Bodor, N.; Pop, E. J. Med. Chem., 1994, 37, 4237.
51. Powell, M.; Wu, J. J. Am. Chem. Soc., 1984, 106, 3850.
52. Ludvik, L; Volke, J.; Kurfurst, A.; Kuthan, J. J. Electroanal. Chem. Interfacial Electrochem., 1982, 138, 131.
53. Schmakel, C.; Santhanam, K.; Elving, P. J. Electrochem. Soc., 1974, 121, 345.
54. Brewster, M. E.; Pop, E.; Huang, M-J.; Bodor, N. Heterocycles, 1994, 37, 1373.
55. Pop, E.; Soti, F.; Anderson, W., Panetta, J. A.; Estes, K. S.; Bodor, N.; Brewster, M.E. Int J. Pharm., 1996, 140, 33.
56. Pop, E.; Anderson, W.; Prokai-Tatrai, K.; Vlasak, J.; Brewster, M. E.; Bodor, N. Med. Chem. Res., 1992, 2, 16.
57. Verbiscar, A. J.; Abood, L G. J. Med. Chem., 1970, 13, 1176.
58. Alexander, J , Cargill, R.; Michelson, S. R.; Schwam, H. J. Med. Chem., 1988, 31, 318.
59. Caldwell, J.; Weil, A.; Tanaka, Y. In Xenobiotic Metabolism and Disposition, Taylor & Francis, London, 1989, pp. 217-224.
60. Chappell, W R.; Mordenti, J. In Advances in Drug Design, Academic Press, Inc., London, 1984; Vol. 20, pp. 1-116.
61. Smith, D. A ; Drug Metab. Rev., 1991, 23, 355.
62. Kawaguchi, T.; Fukushima, S.; Hayashi, Y.; Nakamo, M. Pharm. Res., 1988, 5, 741.
63. Anderson, A. G. Jr.; Berkelhammer, G. J. Am. Chem. Soc., 1958, 80, 992.
64. Chol, K. S.; Alivisitos, G. A. Biochemistry, 1968, 7, 190.
65. Johnson, S. L ; Tuazon, P. T. Biochemistry,1977, 6, 1175.
66. Pop, E.; Huang, M-J.; Brewster, M. E.; Bodor, N. Int. J. Quantum. Chem., 1994, 21, 173.
67. Pop, E.; Liu, Z. Z.; Vlasak, J.; Anderson, W. R.; Brewster, M. E.; Bodor, N. Pharm. Sciences, 1995, 1, 265.